#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	35820	16S	1529	1529	100.0	16S.l6.c4.ctg.1	1999	1765.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1396	1396	C	2001	C	1961	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	35820	16S	1529	1529	100.0	16S.l6.c4.ctg.1	1999	1765.8	0	HET	.	.	.	G395A,C,T	.	395	395	G	607	607	G	1965	G,A,C,T	1475,441,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	66624	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	1812.2	0	.	n	.	0	T695C	SNP	695	695	T	1071	1071	C	2022	C,T	1991,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	66624	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	1812.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1713	1713	A	2128	A,G	2053,31	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	66624	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	1812.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2347	2347	C	2107	C,T	2048,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	66624	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	1812.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2421	2421	A	2081	A	2040	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	66624	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3651	1812.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2973	2973	C	2021	C,T,G	1979,6,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	16	blaTEM	861	394	100.0	blaTEM.l15.c4.ctg.1	394	3.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	4712	folP	855	855	100.0	folP.l15.c30.ctg.1	1711	273.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1132	1134	AGC	464;466;469	A;G;C	461;462;458	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	13198	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3380	387.2	1	SNP	p	S91F	1	.	.	271	273	TTC	631	633	TTC	439;438;438	T;T,C;C,A	429;429,1;426,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	13198	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3380	387.2	1	SNP	p	D95G	1	.	.	283	285	GGC	643	645	GGC	421;422;429	G;G,A;C	410;410,2;420	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	13198	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3380	387.2	1	SNP	p	G95N	0	.	.	283	285	GGC	643	645	GGC	421;422;429	G;G,A;C	410;410,2;420	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	4088	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1347	301.1	1	SNP	p	G45D	0	.	.	133	135	GGC	452	454	GGC	506;506;504	G,C;G;C	497,1;497;495	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	2202	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1037	210.1	0	.	n	.	0	A197.	DEL	197	197	A	656	656	A	495	A	487	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	12130	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	405.2	1	SNP	p	D86N	0	.	.	256	258	GAC	613	615	GAC	486;486;491	G;A;C	479;465;480	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	12130	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	405.2	1	SNP	p	R87I	0	.	.	259	261	CGT	616	618	CGT	487;492;493	C,A;G,A;T	479,2;485,1;483	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	12130	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	405.2	1	SNP	p	S87R	1	.	.	259	261	CGT	616	618	CGT	487;492;493	C,A;G,A;T	479,2;485,1;483	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	12130	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	405.2	1	SNP	p	R87W	0	.	.	259	261	CGT	616	618	CGT	487;492;493	C,A;G,A;T	479,2;485,1;483	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	12130	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2971	405.2	1	SNP	p	S88P	0	.	.	262	264	TCC	619	621	TCC	492;493;494	T;C;C	480;486;487	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	9882	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2571	380.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1525	1527	GGC	490;481;482	G;G;C	481;470;472	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1252	1254	GCA	501;502;506	G;C;A,C	486;486;492,4	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1255	1257	ATC	508;505;502	A;T,C;C,G	493;491,2;484,5	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1267	1269	GTG	505;503;505	G,A,T;T,C;G,C	494,1,1;491,2;494,2	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1267	1269	GTG	505;503;505	G,A,T;T,C;G,C	494,1,1;491,2;494,2	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1771	1773	ACC	415;417;421	A,G,C;C;C,T	395,1,1;410;414,1	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1825	1827	GCG	381;378;380	G;C,G;G	362;328,1;362	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1825	1827	GCG	381;378;380	G;C,G;G	362;328,1;362	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1948	1950	GGC	330;326;323	G;G;C,T	316;312;307,9	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1957	1959	GGC	297;291;288	G,A;G;C,T	270,9;279;271,1	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	9112	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2359	379.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1975	1977	CCG	230;230;232	C,G;C,G;G,C	216,1;211,3;198,2	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	13560	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3058	439.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1658	1660	CCG	471;466;470	C,G;C;G	429,1;444;439	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	6010	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1829	325.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	616	616	C	406	C,G	389,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	6636	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1564	419.4	0	.	p	.	0	E48G	NONSYN	142	144	GAA	427	429	GGA	521;516;524	G,T;G,C;A	502,1;505,1;510	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	6636	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1564	419.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	916	916	T	495	T	474	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	6636	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1564	419.4	1	SNP	p	G120K	0	.	.	358	360	GGT	643	645	GGT	487;486;487	G,A;G,A;T,G	465,5;464,6;442,5	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	6636	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1564	419.4	1	SNP	p	A121D	0	.	.	361	363	GCC	646	648	GCC	489;488;490	G,A;C,A,T;C	464,6;467,8,1;475	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	6636	porB1b	1035	1035	98.57	porB1b.l6.c4.ctg.1	1564	419.4	1	SNP	p	A121N	0	.	.	361	363	GCC	646	648	GCC	489;488;490	G,A;C,A,T;C	464,6;467,8,1;475	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	24170	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4799	499.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	2654	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	899	291.7	1	SNP	p	V57M	1	.	.	169	171	ATG	431	433	ATG	527;534;530	A;T;G	519;522;515	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
